Abstract

BackgroundVeno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m2. The present study in an animal model with similar CO2 production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCO2R.MethodsFour different membrane lungs, with varying lung surface areas of 0.4, 0.8, 1.0, and 1.3m2 were used to perform vv-ECCO2R in seven anesthetized, mechanically ventilated, pigs with experimentally induced severe respiratory acidosis (pH 7.0–7.1) using a 20Fr double-lumen catheter with a sweep gas flow rate of 8 L/min. During each experiment, the blood flow was increased stepwise from 250 to 1000 ml/min.ResultsAmelioration of severe respiratory acidosis was only feasible when blood flow rates from 750 to 1000 ml/min were used with a membrane lung surface area of at least 0.8 m2. Maximal CO2 elimination was 150.8 ml/min, with pH increasing from 7.01 to 7.30 (blood flow 1000 ml/min; membrane lung 1.3 m2). The membrane lung with a surface of 0.4 m2 allowed a maximum CO2 elimination rate of 71.7 mL/min, which did not result in the normalization of pH, even with a blood flow rate of 1000 ml/min. Also of note, an increase of the surface area above 1.0 m2 did not result in substantially higher CO2 elimination rates. The pressure drop across the oxygenator was considerably lower (<10 mmHg) in the largest membrane lung, whereas the smallest revealed a pressure drop of more than 50 mmHg with 1000 ml blood flow/min.ConclusionsIn this porcine model, vv-ECCO2R was most effective when using blood flow rates ranging between 750 and 1000 ml/min, with a membrane lung surface of at least 0.8 m2. In contrast, low blood flow rates (250–500 ml/min) were not sufficient to completely correct severe respiratory acidosis, irrespective of the surface area of the membrane lung being used. The converse was also true, low surface membrane lungs (0.4 m2) were not capable of completely correcting severe respiratory acidosis across the range of blood flows used in this study.

Highlights

  • Veno-venous extracorporeal CO2 removal (vv-Extracorporeal CO2 removal (ECCO2R)) is increasingly being used in the setting of acute respiratory failure

  • ECCO2R was most effective across all membrane sizes with the highest blood flow rate of 1000 ml/min (Figs. 1, 2, 3, and 4, Tables 1, 2, and 3)

  • The main findings of the present porcine study are that the surface area of the membrane lungs substantially impacts the ability to remove CO2 when using vv-ECCO2R, and that there is an important interplay between the size of the membrane lung and the chosen blood flow rate

Read more

Summary

Introduction

Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. The present study in an animal model with similar CO2 production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCO2R. Extracorporeal CO2 removal (ECCO2R) is increasingly recognized as a potentially valuable therapeutic option for patients with acute respiratory failure. Pumpless arterio-venous extracorporeal CO2 removal (av-ECCO2R), using the natural pressure gradient between the peripheral arterial and venous system to drive blood across the membrane oxygenator, as well as pump-driven veno-venous ECCO2R, are both currently used in clinical practice [7, 10]. Epidemiological data has shown that the number of patients receiving av-ECCO2R is steadily decreasing, while the number of those receiving vv-ECCO2R, is increasing over time [11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call